TG Therapeutics | TGTX - Creditori Commerciali

Prezzo Delle Azioni
33.79
Cambio Giornaliero
0.06 0.18%
Mensile
17.45%
Annuale
-12.03%
Q2 Previsione
32.81




Creditori Commerciali Cambiamento Data
AbbVie USD 3.59B 28.65B 2025-12
Alaunos Therapeutics USD 843K 34K 2025-09
Amgen USD 20.89B 1.25B 2025-12
Ardelyx USD 19.24M 845K 2025-12
Arrowhead Research USD 32.94M 15.26M 2025-12
Bayer EUR 7.08B 700M 2025-12
Biogen USD 432M 18.9M 2025-12
Corcept Therapeutics USD 40.44M 6M 2025-12
Curis USD 5.61M 1.52M 2025-12
Gilead Sciences USD 808M 226M 2025-09
Infinity Pharmaceuticals USD 1.5M 433K 2023-06
J&J USD 11.99B 2.37B 2025-12
Karyopharm Therapeutics USD 4M 1.39M 2025-12
Novartis USD 4.46B 99M 2025-12
Novavax USD 24.58M 9.35M 2025-12
PTC Therapeutics USD 45.49M 8.87M 2025-12
Puma Biotechnology USD 6.39M 962K 2025-09
Regeneron Pharmaceuticals USD 5.83B 4.93B 2025-12
Roche Holding CHF 5.78B 1.27B 2025-12
TG Therapeutics USD 61.64M 72.38M 2025-09
Verastem USD 12.45M 2.56M 2025-12
Vertex Pharmaceuticals USD 3.43B 600.9M 2025-12